35 related articles for article (PubMed ID: 27170270)
1.
Binkley MS; Jeon YJ; Nesselbush M; Moding EJ; Nabet BY; Almanza D; Kunder C; Stehr H; Yoo CH; Rhee S; Xiang M; Chabon JJ; Hamilton E; Kurtz DM; Gojenola L; Owen SG; Ko RB; Shin JH; Maxim PG; Lui NS; Backhus LM; Berry MF; Shrager JB; Ramchandran KJ; Padda SK; Das M; Neal JW; Wakelee HA; Alizadeh AA; Loo BW; Diehn M
Cancer Discov; 2020 Dec; 10(12):1826-1841. PubMed ID: 33071215
[TBL] [Abstract][Full Text] [Related]
2. Impact on the Clinical Evolution of Patients with COVID-19 Pneumonia and the Participation of the
Soto ME; Fuentevilla-Álvarez G; Palacios-Chavarría A; Vázquez RRV; Herrera-Bello H; Moreno-Castañeda L; Torres-Paz YE; González-Moyotl NJ; Pérez-Torres I; Aisa-Alvarez A; Manzano-Pech L; Pérez-Torres I; Huesca-Gómez C; Gamboa R
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613859
[TBL] [Abstract][Full Text] [Related]
3. miR-155 overexpression is followed by downregulation of its target gene, NFE2L2, and altered pattern of VEGFA expression in the liver of melanoma B16-bearing mice at the premetastatic stage.
Aksenenko MB; Palkina NV; Sergeeva ON; Yu Sergeeva E; Kirichenko AK; Ruksha TG
Int J Exp Pathol; 2019 Oct; 100(5-6):311-319. PubMed ID: 32043657
[TBL] [Abstract][Full Text] [Related]
4. Differential BMI1, TWIST1, SNAI2 mRNA expression pattern correlation with malignancy type in a spectrum of common cutaneous malignancies: basal cell carcinoma, squamous cell carcinoma, and melanoma.
Vand-Rajabpour F; Sadeghipour N; Saee-Rad S; Fathi H; Noormohammadpour P; Yaseri M; Hesari KK; Bagherpour Z; Tabrizi M
Clin Transl Oncol; 2017 Apr; 19(4):489-497. PubMed ID: 27718152
[TBL] [Abstract][Full Text] [Related]
5. The dual role of Nrf2 in melanoma: a systematic review.
Malakoutikhah Z; Mohajeri Z; Dana N; Haghjooy Javanmard S
BMC Mol Cell Biol; 2023 Feb; 24(1):5. PubMed ID: 36747120
[TBL] [Abstract][Full Text] [Related]
6. NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma.
Immonen A; Haapasaari KM; Skarp S; Karihtala P; Teppo HR
Oxid Med Cell Longev; 2022; 2022():2240223. PubMed ID: 35378827
[TBL] [Abstract][Full Text] [Related]
7. Oxidative Stress-Related Mechanisms in Melanoma and in the Acquired Resistance to Targeted Therapies.
Pizzimenti S; Ribero S; Cucci MA; Grattarola M; Monge C; Dianzani C; Barrera G; Muzio G
Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943045
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional analysis of cleft palate in TGFβ3 mutant mice.
Liu J; Chanumolu SK; White KM; Albahrani M; Otu HH; Nawshad A
Sci Rep; 2020 Sep; 10(1):14940. PubMed ID: 32913205
[TBL] [Abstract][Full Text] [Related]
9. NRF1 and NRF2 mRNA and Protein Expression Decrease Early during Melanoma Carcinogenesis: An Insight into Survival and MicroRNAs.
Hämäläinen M; Teppo HR; Skarp S; Haapasaari KM; Porvari K; Vuopala K; Kietzmann T; Karihtala P
Oxid Med Cell Longev; 2019; 2019():2647068. PubMed ID: 31687076
[TBL] [Abstract][Full Text] [Related]
10. Nuclear factor erythroid 2-related factors 1 and 2 are able to define the worst prognosis group among high-risk diffuse large B cell lymphomas treated with R-CHOEP.
Kari E; Teppo HR; Haapasaari KM; Kuusisto MEL; Lemma A; Karihtala P; Pirinen R; Soini Y; Jantunen E; Turpeenniemi-Hujanen T; Kuittinen O
J Clin Pathol; 2019 Apr; 72(4):316-321. PubMed ID: 30755497
[TBL] [Abstract][Full Text] [Related]
11. Identification of novel targetable mutations in metastatic anorectal melanoma by next-generation sequencing.
Cai ED; Kim J
JAAD Case Rep; 2017 Nov; 3(6):539-541. PubMed ID: 29264386
[No Abstract] [Full Text] [Related]
12. Nrf2/Keap1 Pathway and Expression of Oxidative Stress Lesions 8-hydroxy-2'-deoxyguanosine and Nitrotyrosine in Melanoma.
Hintsala HR; Jokinen E; Haapasaari KM; Moza M; Ristimäki A; Soini Y; Koivunen J; Karihtala P
Anticancer Res; 2016 Apr; 36(4):1497-506. PubMed ID: 27069125
[TBL] [Abstract][Full Text] [Related]
13. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer.
Hung JJ; Yang MH; Hsu HS; Hsu WH; Liu JS; Wu KJ
Thorax; 2009 Dec; 64(12):1082-9. PubMed ID: 19778933
[TBL] [Abstract][Full Text] [Related]
15. AKT-ions with a TWIST between EMT and MET.
Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
[TBL] [Abstract][Full Text] [Related]
16. An immunohistochemical study of NFE2L2, KEAP1 and 8-hydroxy-2'-deoxyguanosine and the EMT markers SNAI2, ZEB1 and TWIST1 in metastatic melanoma.
Hintsala HR; Haapasaari KM; Soini Y; Karihtala P
Histol Histopathol; 2017 Feb; 32(2):129-136. PubMed ID: 27170270
[TBL] [Abstract][Full Text] [Related]
17. EMT-associated factors promote invasive properties of uveal melanoma cells.
Asnaghi L; Gezgin G; Tripathy A; Handa JT; Merbs SL; van der Velden PA; Jager MJ; Harbour JW; Eberhart CG
Mol Vis; 2015; 21():919-29. PubMed ID: 26321866
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
